000 01667 a2200517 4500
005 20250516185648.0
264 0 _c20140303
008 201403s 0 0 eng d
022 _a1558-8238
024 7 _a10.1172/JCI67968
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGuo, Shuling
245 0 0 _aAntisense oligonucleotide treatment ameliorates alpha-1 antitrypsin-related liver disease in mice.
_h[electronic resource]
260 _bThe Journal of clinical investigation
_cJan 2014
300 _a251-61 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aFemale
650 0 4 _aGene Knockdown Techniques
650 0 4 _aHep G2 Cells
650 0 4 _aHepatocytes
_xenzymology
650 0 4 _aHumans
650 0 4 _aLiver
_xenzymology
650 0 4 _aLiver Cirrhosis
_xenzymology
650 0 4 _aMacaca fascicularis
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aMice, Transgenic
650 0 4 _aOligonucleotides, Antisense
_xgenetics
650 0 4 _aRNA, Messenger
_xgenetics
650 0 4 _aalpha 1-Antitrypsin
_xgenetics
650 0 4 _aalpha 1-Antitrypsin Deficiency
_xenzymology
700 1 _aBooten, Sheri L
700 1 _aAghajan, Mariam
700 1 _aHung, Gene
700 1 _aZhao, Chenguang
700 1 _aBlomenkamp, Keith
700 1 _aGattis, Danielle
700 1 _aWatt, Andrew
700 1 _aFreier, Susan M
700 1 _aTeckman, Jeffery H
700 1 _aMcCaleb, Michael L
700 1 _aMonia, Brett P
773 0 _tThe Journal of clinical investigation
_gvol. 124
_gno. 1
_gp. 251-61
856 4 0 _uhttps://doi.org/10.1172/JCI67968
_zAvailable from publisher's website
999 _c23384106
_d23384106